EOLS Evolus, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Evolus, Inc. (EOLS) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 3, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on March 13, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Evolus, Inc. (EOLS) (SEC CIK 1570562), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 5.02: Departure/Appointment of Directors or Principal Officers
- • Vikram Malik reclassified from Class III to Class II director on March 13, 2026 to rebalance Evolus's classified board after Simone Blank's departure
- • Malik retains Chairman of the Board and Compensation Committee roles — no change in influence or oversight function
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings results released March 3, 2026 — full figures in Exhibit 99.1
- • EOLS is a medical aesthetics company (neuromodulator Jeuveau); results reflect competitive botulinum toxin market dynamics
Item 1.01: Entry into a Material Definitive Agreement
- • New $30M senior secured revolving credit facility with Eclipse Business Capital, maturing March 3, 2029
- • Interest rate: SOFR (2.0% floor) + 4.25% margin, with potential downward adjustments based on coverage ratio and availability
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Evolus, Inc. (EOLS) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 13, 2026 | — | Analysis | — |
10-K | Mar 3, 2026 | Dec 31, 2025 | — | |
8-K | Mar 3, 2026 | — | Analysis | — |
8-K | Jan 9, 2026 | — | — | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 5, 2025 | Jun 30, 2025 | — | |
10-Q | May 7, 2025 | Mar 31, 2025 | — | |
10-K | Mar 4, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 6, 2024 | Sep 30, 2024 | — | |
10-Q | Jul 31, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Mar 7, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 2, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Mar 8, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 8, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 2, 2022 | Jun 30, 2022 | — | |
10-Q | May 10, 2022 | Mar 31, 2022 | — | |
10-K | Mar 3, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 2, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 4, 2021 | Jun 30, 2021 | — | |
10-Q | May 12, 2021 | Mar 31, 2021 | — | |
10-K | Mar 25, 2021 | Dec 31, 2020 | — | |
10-Q | Oct 29, 2020 | Sep 30, 2020 | — |
Frequently Asked Questions
What are the latest EOLS SEC filings in 2026?
Evolus, Inc. (EOLS) has filed a 10-K annual report on March 3, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on March 13, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did EOLS file its most recent 10-K annual report?
Evolus, Inc. (EOLS) filed its most recent 10-K annual report on March 3, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view EOLS 10-Q quarterly reports?
Evolus, Inc. (EOLS)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every EOLS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has EOLS filed recently?
Evolus, Inc. (EOLS)'s most recent 8-K was filed on March 13, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find EOLS insider trading activity (Form 4)?
SignalX aggregates every EOLS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does EOLS file with the SEC?
Evolus, Inc. (EOLS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new EOLS filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Evolus, Inc. (EOLS).
What is EOLS's SEC CIK number?
Evolus, Inc. (EOLS)'s SEC CIK (Central Index Key) number is 1570562. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1570562 to look up all EOLS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find EOLS return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Evolus, Inc. (EOLS) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Evolus, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 36+ filings.